Q Therapeutics Inc.
Q Therapeutics Inc. develops neural stem cell-based therapeutic products for debilitating diseases of the central nervous system. Q Therapeutics is developing natural cell-based products that regenerate insulating myelin on damaged neurons with the goal of restoring normal neuron function. The company’s first product, Q-Cells®, are glial progenitor cells and their progeny purified from various tissue sources. Q-Cells address a wide range of diseases, including multiple sclerosis (MS), transverse myelitis, cerebral palsy, spinal cord injury, and certain types of stroke.
Stem cell discoveries covering certain cells of the central nervous system—made by a Weill Cornell Medicine faculty member—have contributed to Q Therapeutics’ broad patent portfolio.